PECULIARITIES OF THE COURSE OF CHRONIC HEART FAILURE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND THE SIGNIFICANCE OF PROGNOSTIC MARKERS

Аннотация

Relevance. Cardiovascular diseases remain the main cause of death and disability in patients with type 2 diabetes mellitus (DM 2) DM 2 aggravates the underlying mechanisms of atherosclerosis and heart failure. Goal. To study the features of the course of CHF in patients with type 2 diabetes mellitus and Material and methods. 80 patients (prospectively) with type 2 diabetes were examined at the Acad. V.V. Vakhidov. Of these, there were 29 women and 51 men. The average age of men was 67 ± 4.2 years, and the average age of women was 64 ± 5.6 years. 10 patients with DM 2 without coronary artery disease of the corresponding age made up the control group. The study used clinical and biochemical research methods (glycemia, glycated hemoglobin, ALT, AST, bilirubin, urea, creatinine, PTI, studies of CHF biomarkers (galectin-3, H-FABR), as well as instrumental methods of examination-ultrasound of internal organs, ECG, Echo-ECG, as well as statistical techniques. Results. The mean values of galectin 3 and H-FABR in the preoperative period were normal in patients of groups 2 and 4, but were significantly high in patients of groups 1 and 3, that is, with a combination of DM 2 and CHF, approaching critical threshold values. Thus, the average values of galectin-3 in the 1st group of patients were within 8.68±0.04 ng/ml, and in the group 7.62±0.08 ng/ml. The average H-FABR data in group 1 reached 17.1±0.4 ng/ml, and in the group 13.5±0.7 ng/ml. Conclusion. The increase in the concentration of Galectin-3 and H-FABR in all patients with type 2 DM with concomitant CHF, as well as the high sensitivity and specificity of the test, prove the value of this marker for diagnosing CHF in patients with type 2 DM.